Future studies integrating MYC protein expression with assays of NF-κB pathway activation, in the context of the aforementioned chromosomal and genetic alterations, would be worthwhile in determining their role in MYC overexpression in CNS DLBCL. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.